Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 63 results for "for merck"

Merck cholesterol drug Vytorin faces competition from Impax, Teva generics

Merck heart drug surprises with positive result; questions linger

(Reuters) - Merck & Co said on Tuesday its experimental cholesterol drug from a class with a history of consistent failure lowered deaths and heart attacks in a large trial, but the company has yet to decide whether to seek approval despite the surprise ... Reuters, 17 hours ago

721 images for for merck

DNA, 1 month ago
Reuters, 2 months ago
Reuters, 3 months ago
Money Control, 3 months ago
Money Control, 3 months ago
Reuters, 3 months ago
WKRB News, 4 months ago
American Banking News, 4 months ago
Technology Networks, 4 months ago
Deccan Chronicle, 4 months ago

Merck shares climb over 6 pc on strong Q4 show

Shares of drug firm Merck today soared over 6 per cent after the company reported a 76.42 per cent increase in net profit for the quarter ended March 31. After opening on a positive note, the stock rose 5.86 per cent to Rs 1,140 as the session progressed on ...
 Business Standard1 month ago Merck shares climb over 6% on strong Q4 show  DNA1 month ago Merck Q4 net profit jumps 76% to Rs 15 cr  Money Control1 month ago

US FDA accepts application of Sun Pharma's partner Merck for tildrakizumab

Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis BS B2B Bureau | Mumbai May 24, 2017 Last Updated at 14:04 IST Sun Pharmaceutical Industries Ltd has announced that the US Food and Drug Administration (FDA) has accepted the ...
 Business Standard1 month ago

Merck opens first India M Lab in Bengaluru to help biopharma firms scale

Lab will also help with technology absorption, making drugs for clinical trials and regulatory nods
 Business Standard1 month ago

Merck expands M Lab Collaboration Center in Bengaluru

Merck, a leading science and technology company in healthcare, life science and performance material, today announced the expansion of its 'M Lab Collaboration Center' in Bengaluru.
 DNA1 month ago

Stocks in news: LT, Idea, HPCL, NHPC, KRBL, Merck, BEML, Varun

LT | Idea Cellular | ONGC | HPCL | Coal India | Sambhaav Media | Quess Corp | Merck | Assam Company | NHPC | Kohinoor Foods | LT Foods | KRBL | Adani Enterprises | Varun Beverages and BEML are stocks, which are in the news today.
 Money Control2 months ago

Volumes jump at HCG counter

Tata Motors, Max India, Himatsingka Seide and Merck are among the other stocks to see a surge in volumes on BSE today, 23 June 2017.
 Business Standard4 days ago

Scientists find new biomarker to guide cancer immunotherapy

Drugs such as Merck & Co's Keytruda, Bristol-Myers Squibb's Opdivo, Roche's Tecentriq and AstraZeneca's Imfinzi can boost the immune system's ability to fight tumours, but they only work for some patients.
 DNA1 week ago The cost of cancer: new drugs show success at a steep price  DNA2 months ago

Merck standalone net profit rises 76.55% in the March 2017 quarter

Sales rise 9.32% to Rs 229.88 crore
 Business Standard1 month ago Merck in pink of health after strong Q1 show  Business Standard1 month ago

Vaccine alliance says 300,000 doses of Merck's Ebola shot available for emergencies

The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a large-scale outbreak, after the World Health Organization confirmed a fatal case in Congo.
 DNA1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less